New GlaxoSmithKline CEO prepares for R&D choices, potential deals – Reuters


Reuters

New GlaxoSmithKline CEO prepares for R&D choices, potential deals
Reuters
By Ben Hirschler | LONDON. LONDON Emma Walmsley, GlaxoSmithKline’s (GSK.L) incoming CEO, will take over Britain’s biggest drugmaker at a challenging time but the 47-year-old also inherits the flexibility to do deals and make key choices on new drugs.

and more »

Read More…

Share This: